Centers for Disease Control and Prevention director Dr. Rochelle Walensky renewed her call for parents to vaccinate teenagers. In doing so, she pointed to the increasing number of adolescents requiring hospitalization for COVID-19 treatment. (The Washington Post)

Merck’s blockbuster cancer drug Keytruda decreased the risk of relapse or death by 32% in patients with renal cell carcinoma after kidney removal. The Phase III results were presented at #ASCO21 this weekend. (Endpoints News)

As part of its expansion into virtual care, Carbon Health has acquired digital diabetes clinic Steady Health. The company has also brought in well-regarded digital health veteran Nita Sommers as its chief growth officer. (STAT)

Several states are struggling to gather racial data on vaccination rates. Experts worry inconsistent data could ultimately perpetuate vaccination disparities. (Kaiser Health News)

The U.S. has authorized a lower dose of Regeneron’s COVID-19 antibody treatment for injection. The move eliminates issues with providing higher doses of the drug intravenously, which could lead to delays in treatment. (Reuters)